OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers
Martina Mang Leng Lei, Terence K. Lee
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 89

Showing 26-50 of 89 citing articles:

Glioblastoma stem cell metabolism and immunity
Joseph Hawly, Micaela G. Murcar, Alejandro Schcolnik‐Cabrera, et al.
Cancer and Metastasis Reviews (2024)
Closed Access | Times Cited: 3

Immune Response and Metastasis—Links between the Metastasis Driver MACC1 and Cancer Immune Escape Strategies
Sebastian Torke, Wolfgang Walther, Ulrike Stein
Cancers (2024) Vol. 16, Iss. 7, pp. 1330-1330
Open Access | Times Cited: 3

Role of Cancer Stem Cells in Drug Resistance
Kaneez Fatima, Shariqa Jan, Fayaz Malik, et al.
(2024), pp. 77-120
Closed Access | Times Cited: 3

Chronic High-Salt Diet Activates Tumor-Initiating Stem Cells Leading to Breast Cancer Proliferation
Lisa Tucker, Umer Ali, Roy Zent, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 912-912
Open Access | Times Cited: 3

Exploring the interplay between triple‐negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies
Zhuoling Zou, Tinglan Luo, Xinyuan Wang, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 8
Closed Access | Times Cited: 3

The missing link between cancer stem cells and immunotherapy
Lobna Safwat Ali, Youssef Attia, Sohaila Mourad, et al.
Current Medical Research and Opinion (2024), pp. 1-35
Closed Access | Times Cited: 3

Tubulin Isotypes: Emerging Roles in Defining Cancer Stem Cell Niche
Tessy Thomas Maliekal, Dhrishya Dharmapal, Suparna Sengupta
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16

Phenotypic, functional, and metabolic heterogeneity of immune cells infiltrating non–small cell lung cancer
Beatrice Aramini, Valentina Masciale, Anna Valeria Samarelli, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16

RNA N6-methyladenosine modification in regulating cancer stem cells and tumor immune microenvironment and its implication for cancer therapy
Subhadra Kumari, Santosh Kumar, Srinivasan Muthuswamy
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 4, pp. 1621-1633
Closed Access | Times Cited: 15

Effects of Dendrimer-microRNA Nanoformulations against Glioblastoma Stem Cells
Nadezhda Knauer, Mariya I. Meschaninova, Sajjad Muhammad, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 968-968
Open Access | Times Cited: 8

The regulatory role of long non- coding RNAs as a novel controller of immune response against cancer cells
Dina Mofed, Jihad I. Omran, Salwa Sabet, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 12, pp. 11775-11793
Open Access | Times Cited: 13

Cancer cells escape the immune system by increasing stemness through epigenetic reprogramming
José A. Costoya, Vı́ctor M. Arce
Cellular and Molecular Immunology (2022) Vol. 20, Iss. 1, pp. 6-7
Open Access | Times Cited: 12

Identification of CAF-related lncRNAs at the pan-cancer level represents a potential carcinogenic risk
Ming‐Wei Wang, Minghui Jiang, Aimin Xie, et al.
Human Molecular Genetics (2024) Vol. 33, Iss. 12, pp. 1064-1073
Closed Access | Times Cited: 2

The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular Pathways
Chao Yin, Ali Alqahtani, Marcus Smith Noel
Cancers (2022) Vol. 14, Iss. 11, pp. 2619-2619
Open Access | Times Cited: 11

Mechanisms of immune evasion by head and neck cancer stem cells
Flávia Caló de Aquino Xavier, Jamerson Carvalho Silva, Camila Oliveira Rodini, et al.
Frontiers in Oral Health (2022) Vol. 3
Open Access | Times Cited: 11

Advances in Immunotherapy for the Treatment of Adult Glioblastoma: Overcoming Chemical and Physical Barriers
Mirna Lechpammer, Rohan Rao, Sanjit Shah, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1627-1627
Open Access | Times Cited: 10

Adriamycin‐loaded exosome with anti‐CD20 aptamers selectively suppresses human CD20+ melanoma stem cells
Hairong Chen, Yu‐Xia Jiang, Xia Li
Skin Research and Technology (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 9

The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity
Daria S. Chulpanova, Albert A. Rizvanov, Valeriya V. Solovyeva
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 395-395
Open Access | Times Cited: 9

Targeting Cancer Stem Cells through Epigenetic Modulation of Interferon Response
Chang‐Shen Lin, Siyun Chen, Chang‐Shen Lin
Journal of Personalized Medicine (2022) Vol. 12, Iss. 4, pp. 556-556
Open Access | Times Cited: 8

Reprograming immune microenvironment modulates CD47 cancer stem cells in hepatocellular carcinoma
Eslam E. Abd El-Fattah, Hend Mostafa Selim
International Immunopharmacology (2022) Vol. 113, pp. 109475-109475
Closed Access | Times Cited: 8

Metabolic Plasticity of Cancer Stem Cells in Response to Microenvironmental Cues
Yunong Xie, Stephanie Ma, Man Tong
Cancers (2022) Vol. 14, Iss. 21, pp. 5345-5345
Open Access | Times Cited: 8

Mechanisms of HIF-driven immunosuppression in tumour microenvironment
Shinjini Bandopadhyay, Somi Patranabis
Journal of the Egyptian National Cancer Institute (2023) Vol. 35, Iss. 1
Open Access | Times Cited: 4

Scroll to top